Shuren to wrap up town-halls in S.F.; Neoprobe establishes European business unit;

> CDRH Director Jeffrey Shuren is planning to be in San Francisco in September for the last in a series of town hall-style public meetings for 2011. Story

> Neoprobe has established a European business unit to address EU development and commercialization needs for its novel technologies, including Lymphoseek (99mTc-tilmanocept). Neoprobe release

> Centron Diagnostics, a spin-out of King's College London, recently released a blood pressure monitor that can measure peripheral and central systolic blood pressure with one upper arm cuff. News

> A team of surgeons at South Nassau Communities Hospital using the da Vinci Surgical System recently performed Long Island's first robotic-assisted bilobectomy lung surgery. The procedure is used to remove cancer that involves two lobes of the lung. South Nassau Communities Hospital

> Luminex has received 510(k) clearance from the FDA for its xTAG Respiratory Viral Panel FAST (RVP FAST). This front line test has the potential to significantly change the way respiratory viral testing is performed and complements the company's existing respiratory portfolio. Luminex release

> Molecular Detection and life sciences and diagnostics distributor Eldan, a part on the Neopharm Group, have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA Panel in Israel and the Palestinian territories. MDI/Eldan release

And Finally... New techniques are allowing scientists to hear what neurons are saying--and to talk back. Researchers have spent years trying to eavesdrop on electrochemical signals--neuronal chatter--to figure out what happens when a memory is formed or an emotion is felt.  Scientists have recently moved beyond implanting electrodes and using functional MRI scans to begin harnessing the power of cell culture and microchips. Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.